ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

被引：0

作者：

Parmar, Deven V. ^{[1
]}

Byczkowski, Daniel ^{[1
]}

Jubin, Ronald G. ^{[1
]}

Abuchowski, Abraham ^{[1
]}

Buontempo, Peter ^{[1
]}

Gitlin, Gerry ^{[1
]}

Boro, Michelle ^{[1
]}

Misra, Hemant K. ^{[1
]}

机构：

[1] Prolong Pharmaceut, South Plainfield, NJ USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF A SINGLE ORALLY ADMINISTERED DOSE OF ENPATORAN IN A PHASE I STUDY OF HEALTHY JAPANESE AND CAUCASIAN PARTICIPANTS [J].

Gopalakrishnan, S. ;

Krebs-Brown, A. ;

Nogueira Filho, M. ;

Kuroki, Y. ;

Bachmann, A. ;

Becker, A. ;

Schippers, F. ;

Fluck, M. ;

Yalkinoglu, O. ;

Klopp-Schulze, L. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :663-664

[32] Phase 1 Study of the Safety, Pharmacokinetics and Pharmacodynamics of Teneligliptin, a New DPP-IV Inhibitor, in Healthy Volunteers [J].

Kumagai, Yuji ;

Fujita, Tomoe ;

Kawaguchi, Atsuhiro ;

Hayashi, Yoshiharu ;

Kondou, Kazuoki .

DIABETES, 2010, 59 :A193-A193

[33] A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161 in Chinese healthy volunteers [J].

Yap, D. ;

Zhou, X. ;

Chen, X. ;

Lee, M. ;

Zhang, Y. ;

Wang, M. .

EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 :1178-1179

[34] Ascending-Dose Study of Controlled-Release Ketamine Tablets in Healthy Volunteers: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability [J].

Glue, Paul ;

Medlicott, Natalie J. ;

Surman, Peter ;

Lam, Fred ;

Hung, Noelyn ;

Hung, C. Tak .

JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (06) :751-757

[35] Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single-Dose Study [J].

Zou, Peng ;

Zahir, Hamim ;

Duggal, Anil ;

Pandya, Grishma ;

Jin, James ;

Leil, Tarek A. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (03) :736-746

[36] A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers [J].

Cantarini, MV ;

Macpherson, MP ;

Marshall, AL ;

Robinson, AV ;

Bailey, CJ .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (06) :557-562

[37] A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers [J].

Mireille V. Cantarini ;

Merran P. Macpherson ;

Anna L. Marshall ;

Anna V. Robinson ;

Christopher J. Bailey .

Cancer Chemotherapy and Pharmacology, 2005, 56 :557-562

[38] PHASE 1, DOSE-RANGING STUDY OF EMIXUSTAT HYDROCHLORIDE (ACU-4429), A NOVEL VISUAL CYCLE MODULATOR, IN HEALTHY VOLUNTEERS [J].

Kubota, Ryo ;

Al-Fayoumi, Suliman ;

Mallikaarjun, Suresh ;

Patil, Shiva ;

Bavik, Claes ;

Chandler, John W. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (03) :603-609

[39] Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers [J].

Neiloufar Family ;

Emeline L. Maillet ;

Luke T. J. Williams ;

Erwin Krediet ;

Robin L. Carhart-Harris ;

Tim M. Williams ;

Charles D. Nichols ;

Daniel J. Goble ;

Shlomi Raz .

Psychopharmacology, 2020, 237 :841-853

[40] Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers [J].

Rosario, Maria ;

Wyant, Timothy ;

Leach, Timothy ;

Sankoh, Serap ;

Scholz, Catherine ;

Parikh, Asit ;

Fox, Irving ;

Feagan, Brian G. .

CLINICAL DRUG INVESTIGATION, 2016, 36 (11) :913-923

← 1 2 3 4 5 →